Researchers at the Weizmann Institute of Science and Cambridge University have jointly managed the feat of turning back the clock on human cells to create primordial germ cells, the embryonic cells that give rise to sperm and ova, in the lab. This is the first time that human cells have been programmed into this early developmental stage. The results of their study could help provide answers as to the causes of fertility problems, yield insight into the earliest stages of embryonic development and potentially, in the future, enable the development of new kinds of reproductive technology. The opensource study is published in the journal Cell.
Researchers have been attempting to create human primordial germ cells (PGCs) in the petri dish for years. PGCs arise within the early weeks of embryonic growth, as the embryonic stem cells in the fertilized egg begin to differentiate into the very basic cell types. Once these primordial cells become specified, they continue developing toward precursor sperm cells or ova pretty much on autopilot, state the researchers.
The idea of creating these cells in the lab took off with the 2006 invention of induced pluripotent stem (iPS) cells, adult cells that are reprogrammed to look and act like embryonic stem cells, which can then differentiate into any cell type. Thus several years ago, when researchers in Japan created mouse iPS cells and then got them to differentiate into PGCs, scientists immediately set about trying to replicate the achievement in human cells. But until now, none had been successful.
Previous research in the lab pointed to new methods that could take human cells to the PGC state. That research had focused on the question of how human iPS cells and mouse embryonic cells differ. The mouse embryonic cells are easily kept in their stem cell state in the lab, while human iPS cells that have been reprogrammed, a technique that involves the insertion of four genes, have a strong drive to differentiate; and they often retain traces of priming.
The group then created a method for tuning down the genetic pathway for differentiation, thus creating a new type of iPS cell that they named ‘naïve cells.’ These naïve cells appeared to rejuvenate iPS cells one step further, closer to the original embryonic state from which they can truly differentiate into any cell type. Since these naïve cells are more similar to their mouse counterparts, Hanna and his group thought they could be coaxed to differentiate into primordial germ cells.
Working with naïve human embryonic stem and iPS cells, and applying the techniques that had been successful in the mouse cell experiments, the research team managed to produce cells that, in both cases, appeared to be identical to human PGCs. The scientists further tested and refined the method and added a glowing red fluorescent marker to the genes for PGCs to gauge how many of the cells had been programmed. Their results showed that quite a high rate, up to 40%, had become PGCs, a quantity which enabled easy analysis.
The team state that PGCs are only the first step in creating human sperm and ova. A number of hurdles remain before lab will be able to complete the chain of events that move an adult cell through the cycle of embryonic stem cell and around to sperm or ova. For one, at some point in the process, these cells must learn to perform the neat trick of dividing their DNA in half before they can become viable reproductive cells. Still, the team are confident that those hurdles will one day be overcome, raising the possibility, for example, of enabling women who have undergone chemotherapy or premature menopause to conceive.
In the meantime, the study has already yielded some interesting results that may have significant implications for further research on PGCs and possibly other early embryonic cells. The team managed to trace part of the genetic chain of events that directs a stem cell to differentiate into a primordial germ cell, and they discovered a master gene, Sox17, that regulates the process in humans, but not in mice. Because this gene network is quite different from the one that had been identified in mice, the researchers suspect that more than a few surprises may await scientists who study the process in humans.
Having the ability to create human PGCs in the petri dish will enable the medical community to investigate the process of differentiation on the molecular level. For example, the team found that only ‘fresh’ naïve cells can become PGCs; but after a week in conventional growth conditions they lose this capability once again. The researchers state that they want to know why this is.
In future research the team plan to ask what is it about human stem cell states that makes them more or less competent? And what exactly drives the process of differentiation once a cell has been reprogrammed to its more naïve state? It is the answers to these basic questions that will, ultimately, advance iPS cell technology to the point of medical use.
Source: Weizmann Institute of Science
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.